期刊文献+

SLE患者中DcR3的表达及作用机制的研究 被引量:1

Study on the level of DcR3 and its mechanism of action in patients with systemic lupus erythematosus
原文传递
导出
摘要 目的:探讨DcR3在SLE免疫紊乱过程中发生的变化及其可能作用机制。方法:选择36例SLE患者,以12例健康体检者为对照;采用ELISA法检测血清中的DcR3I、L-4和IFN-γ。结果:SLE组血清DcR3I、L-4和IFN-γ量显著高于正常对照组(P均<0.01);SLE患者中I,FN-γ/IL-4值呈两极化分布特点,以0.76为界,分为较明显的高值组(n=19,1.93±1.14)和低值组(n=170,.53±0.09)I,FN-γ/IL-4低值组的DcR3和IL-4水平比IFN-γ/IL-4高值组和正常对照组均高;DcR3与IL-4呈正相关趋势(r=0.340,P<0.05),与IFN-γ/IL-4呈负相关趋势(r=-0.332,P<0.05)。结论:SLE患者血清DcR3水平显著升高,可能通过促Th2等作用参与SLE的发生发展。 Objective:To explore the alternation of decoy receptor 3(DcR3) and its mechanism of action in the immune pathogenesis of patients with systemic lupus erythematosus(SLE).Methods:36 patients with SLE and 12 healthy volunteers as controls were included in the study.Their serum levels of DcR3,IL-4 and IFN-γ were determined by enzyme linked immunosorbent assay(ELISA).Results:Significantly higher serum of DcR3,IFN-γ and IL-4 concentrations(P0.01)were detected in SLE patients than the healthy volunteers(P0.01).In SLE patients,IFN-γ/IL-4 ratio displayed a polarized distribution,and the SLE patients could be divided into hypso-ratio group(n=19,1.93±1.14)and hypo-ratio group(n=17,0.53±0.09)with the cut-point of 0.76.And the levels of DcR3 and IL-4 of hypo-ratio group were higher than both the hypso-ratio group and control group.DcR3 correlated positively with IL-4(r=0.340,P0.05)and negatively with IFN-γ/IL-4 ratio(r=-0.332,P0.05).Conclusion:The data showed that serum DcR3 concentrations in patients with SLE were significantly elevated.And DcR3 might play important roles in the development of SLE by promoting T helper cells transforming into Th2 cells.
出处 《中国卫生检验杂志》 CAS 2011年第8期1928-1930,共3页 Chinese Journal of Health Laboratory Technology
关键词 系统性红斑狼疮 诱骗受体3 TH1/TH2失衡 Systemic lupus erythematosus Decoy receptor 3 Th1/Th2 imbalance
  • 相关文献

参考文献12

  • 1Lit LC, Wong CK, Li EK, et al. Elevated gene expression of Thl/Th2 associated transcription factors is correlated with disease activity in pa- tients with systemic lupus erythematosus[ J ]. J Rheumatol, 2007, 34 (1) :89 -96. 被引量:1
  • 2Yu KY, Kwon B, Ni J, et al. A newly identified member of tumor necrosis factor receptor superfamily ( TR6 ) suppresses LIGHT - media- ted apoptosis[ J]. J Biol Chem, 1999, 274 (20) :13733 -13736. 被引量:1
  • 3Pitti RM, Marsters SA, Lawrence DV, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer[ J ]. Nature, 1998, 396(6712) :699 -703. 被引量:1
  • 4Hsu TL, Chang YC, Chert SJ, et al. Modulation of dendritic cell differentiation and maturation by decoy receptor 3 [ J ]. J Immunol, 2002, 168(10) :4846 -4853. 被引量:1
  • 5周广宇,杨永净,毕黎琦(审校).系统性红斑狼疮中T细胞作用的研究进展[J].国外医学(免疫学分册),2005,28(5):274-277. 被引量:6
  • 6Otsuki T, Tomokuni A, Sakaguchi H, et al. Over - expression of the decoy receptor 3 ( DcR5 ) gene in peripheral blood mononuclear ceils (PBMC) derived from silicosis patients [ J ]. Clin Exp Immunol, 2000, 119(2) :323 -327. 被引量:1
  • 7Lee CS, Hu CY, Tsai HF, et al. Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematsus [ J 1. Clin Exp Immunol, 2008, 151 (3) :383 - 390. 被引量:1
  • 8Tucci M, Lombardi L, Richards HB, et al. Overexpression of interleu- kin - 12 and T helper 1 predominance in lupus nephritis[ J]. Clin Exp Immunol, 2008, 154(2) :247 -254. 被引量:1
  • 9Shimizu S, Sugiyama N, Masutani K, et al. Membranous glomerulone- phritis development with Th2 - type immune deviations in MRL/lpr mice deficient for IL - 27 receptor( WSX - 1 ) [ J ]. Immunol,2005,175 (11) :7185 -7192. 被引量:1
  • 10Han B, Bojalil R, Amezcua - Guerra LM, et al. DcR3 as a diagnos- tic parameter and risk factor for systemic lupus erythematosus[ J]. Int Immunol, 2008, 20(8 ) : 1067 - 1073. 被引量:1

二级参考文献16

  • 1周广宇,藤尾圭志,俞戎,山本一彦.狼疮模型鼠各脏器中T细胞受体Vβ基因的表达[J].中华风湿病学杂志,2004,8(12):733-736. 被引量:3
  • 2Berden JH. Lupus nephritis: consequence of disturbed removal of apoptotic cells? [J] .Neth J Med,2003,61(8) :233-238. 被引量:1
  • 3Grammer AC,Slota R, Fischer R, et al. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions[J] .J Clin Invest,2003,112(10):1506-1520. 被引量:1
  • 4Charles PJ, Smeenk R J, De Jong J, et al. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha:findings in open-label and randomized placebo-contr olled trials[J].Arthritis Rheum,2000,43(11) :2383-2390. 被引量:1
  • 5Traynor AE, Schroeder J, Rosa RM, et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stemcell transplantation:a phase Ⅰ study[J] .Lancet,2000,356(9231) :701-707. 被引量:1
  • 6Mohan C, Adams S, Stanik V, et al. Nucleosome:a major immunogen for pathogenic autoantibody-inducing T cells of lupus[J]. J Exp Med, 1993,177(5): 1367-1381. 被引量:1
  • 7Masato Y, Hideo Y, Hideko I, et al. Selective accumulation of CDR4 + T lymphocytes intorenal tissue of patients with lupus nephritis[J]. Arthritis Rheum,2002,46(3) :735-740. 被引量:1
  • 8Zhou G,Fujio K,Sadakata A,et al.Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/WF1 lupus model mice[J].Clin Exp Immunol,2004,136(3) :448-455. 被引量:1
  • 9Uhm WS, Na K, Song GW, et al. Cytokine balance in kidney tissue from lupus nephritis patients[J]. Rheumatology,2003,42(8) :935-938. 被引量:1
  • 10Zhou G,Fujio K,Sadakata A,et al. Identification ofsystemically expanded activated T cell clones in MRL/lpr and NZB/WF1 lupus model mice[J].Clin Exp Immunl,2004,136(3) :448-455. 被引量:1

共引文献5

同被引文献13

  • 1段伟宏,苏忠学,吴泰璜.DcR3反义RNA表达载体的构建及表达[J].中国现代普通外科进展,2005,8(1):17-19. 被引量:4
  • 2武忠弼,杨光华.中华外科病理学(上卷)[M].北京:人民卫生出版社,2006:521-39. 被引量:2
  • 3Trotnan LC, Wang X, Alinonti A, et al. Ubiquit ination regulates PTEN nuclear in port and Tumor suppression[ J]. Cell ,2007 ; 128 : 141-56. 被引量:1
  • 4Ryan AE ,Shanahan F ,O Connell J ,et al. Fas ligand promotes tumor immune evasion of colon cancer in vivo[ J]. Cell Cycle ,2006 ;5:246-9. 被引量:1
  • 5Lee CS, Hu CY, Tsai HY. Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosus[ J]. Clin Exp Immunol, 2008 ; 151 ( 3 ) :383-90. 被引量:1
  • 6Macher-Goeppinger S, Aulmann S, Wagener N. Decoy receptor 3 is a prognostic factor in renal cell cancer [ J ]. Neoplasia, 2008 ; 10 ( 10 ) : 1049-56. 被引量:1
  • 7Chen G, Luo D. Over-expression of decoy receptor 3 in gastric precancerous lesion and carcinoma [ J ]. Ups J Med Sci, 2008 ; 113 ( 3 ) : 297- 304. 被引量:1
  • 8You RI, Chang YC, Chen PM. Apoptosis of dendritic cells induced by decoy receptor 3 ( DcR3 ) [ J]. Blood ,2008 ; 111 ( 3 ) : 1480-8. 被引量:1
  • 9李平,黄昌明,张祥福,卢辉山,杨发端,吴心愿,王川,张鲁榕.胃癌组织中诱捕受体3蛋白的表达及临床意义[J].福建医药杂志,2008,30(1):1-3. 被引量:2
  • 10陈罡,党裔武,罗殿中.肝癌细胞系DcR3的表达及意义[J].山东医药,2008,48(18):11-12. 被引量:5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部